Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center.
Elife. 2023 May 30;12:e87537. doi: 10.7554/eLife.87537.
Elife. 2023.
PMID: 37249220
Free PMC article.
Incremental biomarker and clinical outcomes after switch from enzyme therapy to eliglustat substrate reduction therapy in Gaucher disease.
Kleytman N, Ruan J, Ruan A, Zhang B, Murugesan V, Lin H, Guo L, Klinger K, Mistry PK.
Kleytman N, et al.
Mol Genet Metab Rep. 2021 Aug 28;29:100798. doi: 10.1016/j.ymgmr.2021.100798. eCollection 2021 Dec.
Mol Genet Metab Rep. 2021.
PMID: 34485083
Free PMC article.
Item in Clipboard
Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher disease.
Afinogenova Y, Ruan J, Yang R, Kleytman N, Pastores G, Lischuk A, Mistry PK.
Afinogenova Y, et al. Among authors: kleytman n.
Mol Genet Metab. 2019 Sep-Oct;128(1-2):62-67. doi: 10.1016/j.ymgme.2019.07.014. Epub 2019 Jul 23.
Mol Genet Metab. 2019.
PMID: 31358474
Free PMC article.
Item in Clipboard
Cite
Cite